​
​

CNS Pharmaceuticals Ownership | Who Owns CNS Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

CNS Pharmaceuticals Ownership Summary

CNS Pharmaceuticals is owned by 3.20% institutional investors, and 96.80% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.41% of its assets in CNS Pharmaceuticals shares.

CNSP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCNS Pharmaceuticals3.20%-96.80%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202216-5.88%1,282,3897.15%335.84%7-22.22%1-50.00%
Jun 30, 2022176.25%1,196,819-30.11%215.35%9-10.00%2-50.00%
Mar 31, 202216-15.79%1,712,43048.30%422.98%1011.11%433.33%
Dec 31, 20211911.76%1,154,69221.85%436.75%9-3-
Sep 30, 202117-5.56%947,605-28.57%312.69%9-350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index165.24K0.41%164.79K
Fidelity Series Total Market Index37.94K0.09%37.85K
Vanguard Institutional Extnd Mkt Idx Tr1.17K0.00%-
Northern Trust Extended Eq Market Idx9.00--
SSgA U.S. Total Market Index Strategy5.00-1.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 51.00-1.00
Spartan Extended Market Index Pool E2.00-2.00
State St US Extended Mkt Indx NL Cl C12.00--
SSgA U.S. Extended Market Index Class I600.00--
NT Ext Equity Mkt Idx Fd - L9.00--

Recent Insider Transactions

DateNameRoleActivityValue
Feb 01, 2024Gumulka Jerzy-Buy$10.00K
Feb 01, 2024Evans Carl Anthony-Buy$10.00K
Feb 01, 2024Downs Christopher Chief Financial OfficerBuy$20.00K
Feb 01, 2024Climaco John M Chief Executive OfficerBuy$50.00K
Aug 22, 2023Downs Christopher Chief Financial OfficerBuy$34.18K

Insider Transactions Trends

DateBuySell
2023 Q32-
2023 Q24-
2023 Q1-13
2022 Q4-4
2022 Q2--

CNSP Ownership FAQ

Who Owns CNS Pharmaceuticals?

CNS Pharmaceuticals shareholders are primarily institutional investors at 3.20%, followed by 0% insiders and 0% retail investors. The average institutional ownership in CNS Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which CNS Pharmaceuticals falls below.

Does Blackrock own CNS Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of CNS Pharmaceuticals.

Who is the top mutual fund holder of CNS Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of CNS Pharmaceuticals shares, with 0.41% of its total shares outstanding invested in 165.24K CNS Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools